NCT04330534 - First-in-Human Study of BCX9930 in Healthy Volunteers and Patients With PNH | Biotech Hunter

Enrollment

168

Participants

Timeline

Start Date

March 3, 2020

Primary Completion Date

November 11, 2020

Study Completion Date

January 25, 2021

Conditions

Paroxysmal Nocturnal Hemoglobinuria

Interventions

DRUG

BCX9930

BCX9930 capsules for oral administration

DRUG

Placebo

placebo to match BCX9930 capsules for oral administration

Trial Locations (4)

Study Site, Vienna

Study Site, Bloemfontein

Study Site, Pretoria

Study Site, London